Clinical trial
Evaluation of Clinical Efficacy and Prognosis in Patients With Hypertrophic Obstructive Cardiomyopathy Through Hemodynamic Modeling Reconstructed by CT
NCT06683872 is registered in ClinicalTrials.gov with Zhejiang Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Clinical Efficacy and Prognosis in Patients With Hypertrophic Obstructive Cardiomyopathy Through Hemodynamic Modeling Reconstructed by CT
- Lead sponsor
- Zhejiang Provincial People's Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- August 1, 2024
- Completion date
- August 31, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertrophic cardiomyopathy (hcm)